Vitoria (EFE).- The women’s race has brought together more than 3,000 runners in Vitoria in a race that seeks to raise money to fight against breast cancer and defend the role of women and athletes in society.
The test, of 5.5 kilometers and which is not competitive, started at 10:30 am from the Mendizabala car park, from where a pink tide left in the direction of Portal de Lasarte and then completed a circular route that ended in the starting point.
The first to cross the finish line was Sara Reimondo from Asturias, who was fifth in Madrid and who reached the finish line in less than 21 minutes.
In the moments before the race, tribute was paid to the gymnast from Vitoria Almudena Cid, who also took part in the race, and to the international wheelchair basketball players Naiara Rodríguez, Agurtzane Egiluz and Laura Ugarte.
The Vitoria women’s race is the fourth event of a national circuit whose objectives include incorporating women of all ages into the regular practice of sport, fighting cancer, raising awareness about the importance of prevention and promoting habits healthy lifestyles to avoid it as much as possible.
Fight against sexist violence
It is also intended to combat and make visible the fight against sexist violence. Thus, all the participants wear the same number, 016, as the telephone number for attention to victims of gender violence and that does not leave any trace on the telephone bill, although it must be deleted from the call history on the mobile .
Before arriving in the capital of Álava, the women’s race was held in Gran Canaria, Valencia and Madrid. The next appointment will be in Gijón on June 18 and after the summer the calendar will continue in A Coruña, Seville, Zaragoza and Barcelona, where 32,000 runners gathered last year.
This test has a spirit of solidarity that translates into a contribution of 75,000 euros to the Spanish Association Against Cancer. In addition, in Vitoria it has been possible to acquire 50 numbers in favor of the Alavesa Association of Women with Breast and Gynecological Cancer.